Dennis Brown

1.6k total citations
77 papers, 1.1k citations indexed

About

Dennis Brown is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dennis Brown has authored 77 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Genetics and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dennis Brown's work include Glioma Diagnosis and Treatment (20 papers), Cancer therapeutics and mechanisms (12 papers) and DNA Repair Mechanisms (8 papers). Dennis Brown is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), Cancer therapeutics and mechanisms (12 papers) and DNA Repair Mechanisms (8 papers). Dennis Brown collaborates with scholars based in United States, Canada and China. Dennis Brown's co-authors include Ning Yu, William W. Lee, Jeremy Brown, Elaine K. Orenberg, Norman I. Dowling, J. Martin Brown, J. B. Hyne, B. L. Bhatt, Francis J. Waller and Sarathchandra Kanekal and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Dennis Brown

73 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dennis Brown United States 20 235 229 159 155 148 77 1.1k
Priyanka Srivastava India 23 377 1.6× 138 0.6× 91 0.6× 246 1.6× 223 1.5× 154 1.5k
Yusuke Sasaki Japan 21 496 2.1× 199 0.9× 126 0.8× 47 0.3× 337 2.3× 98 1.4k
Xiaofei Zhou United States 20 431 1.8× 109 0.5× 88 0.6× 73 0.5× 455 3.1× 79 1.2k
Lihua Qiu China 31 964 4.1× 286 1.2× 184 1.2× 424 2.7× 362 2.4× 94 2.8k
Cristina Valero United States 25 134 0.6× 174 0.8× 54 0.3× 171 1.1× 615 4.2× 72 1.8k
Ziwei Huang China 32 665 2.8× 158 0.7× 127 0.8× 95 0.6× 707 4.8× 99 2.7k
Xiaolu Yin China 21 600 2.6× 764 3.3× 118 0.7× 301 1.9× 775 5.2× 73 1.8k
M. Hanson United States 23 411 1.7× 124 0.5× 178 1.1× 82 0.5× 369 2.5× 51 1.6k

Countries citing papers authored by Dennis Brown

Since Specialization
Citations

This map shows the geographic impact of Dennis Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Brown more than expected).

Fields of papers citing papers by Dennis Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Brown. The network helps show where Dennis Brown may publish in the future.

Co-authorship network of co-authors of Dennis Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Brown. A scholar is included among the top collaborators of Dennis Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Brown. Dennis Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhai, Beibei, Fariba Ghaidi, Michael M. Lizardo, et al.. (2023). A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma. Clinical Cancer Research. 29(17). 3541–3553. 19 indexed citations
2.
Fiebig, Klaus M., et al.. (2021). Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial. EClinicalMedicine. 40. 101124–101124. 8 indexed citations
4.
Zhai, Beibei, Yue Li, Sudha Sravanti Kotapalli, et al.. (2020). Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells. Cell Death and Disease. 11(7). 577–577. 4 indexed citations
5.
Zhai, Beibei, et al.. (2018). Dianhydrogalactitol induces replication-dependent DNA damage in tumor cells preferentially resolved by homologous recombination. Cell Death and Disease. 9(10). 1016–1016. 8 indexed citations
6.
Brown, Dennis, et al.. (2018). Assessing Drug Price Changes Over 1 Year and their Influence on Budget Impact. Value in Health. 21. S222–S222. 1 indexed citations
7.
Shih, Kent C., Manish R. Patel, Nicholas Butowski, et al.. (2016). Phase I/II study of VAL-083 in patients with recurrent glioblastoma.. Journal of Clinical Oncology. 34(15_suppl). 2063–2063. 2 indexed citations
8.
Yoshida, Yasuyuki, Tomoko Ozawa, Shen Wang, et al.. (2014). NT113, a Pan-ERBB Inhibitor with High Brain Penetrance, Inhibits the Growth of Glioblastoma Xenografts with EGFR Amplification. Molecular Cancer Therapeutics. 13(12). 2919–2929. 15 indexed citations
9.
Shih, Kent C., Manish R. Patel, Dennis Brown, et al.. (2014). Abstract CT404: Phase I/II study of VAL-083 in patients with recurrent glioblastoma multiforme. Cancer Research. 74(19_Supplement). CT404–CT404. 1 indexed citations
10.
Hu, Kaiji, Abbas Fotovati, James Chen, et al.. (2012). Abstract 811: VAL083, a novel N7 alkylating agent, surpasses temozolomide activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme. Cancer Research. 72(8_Supplement). 811–811. 1 indexed citations
11.
Brown, Dennis, et al.. (2007). Design and evaluation of oral delivery dosage forms of homoharringtonine. Cancer Research. 67. 4730–4730. 4 indexed citations
12.
Brown, Dennis, et al.. (2004). Preclinical development of novel naphthalimide formulations. Cancer Research. 64. 1057–1057. 1 indexed citations
13.
Brown, Dennis. (2003). Drug Delivery Systems in Cancer Therapy. Humana Press eBooks. 58 indexed citations
14.
Yu, Ning, et al.. (1995). Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice. Cancer Chemotherapy and Pharmacology. 36(1). 27–34. 23 indexed citations
15.
Orenberg, Elaine K., et al.. (1995). Intralesional sustained-release chemotherapy with therapeutic implants for treatment of canine sun-induced squamous cell carcinoma. European Journal of Cancer. 31(12). 2093–2098. 20 indexed citations
16.
Orenberg, Elaine K., Bruce Miller, Hubert T. Greenway, et al.. (1992). The effect of intralesional 5-Fluorouracil Therapeutic Implant (MPI 5003) for treatment of basal cell carcinoma. Journal of the American Academy of Dermatology. 27(5). 723–728. 36 indexed citations
17.
Honnas, Clifford M., et al.. (1990). Malignant melanoma in the foot of a horse. Journal of the American Veterinary Medical Association. 197(6). 756–758. 33 indexed citations
18.
Horsman, Michael R., Dennis Brown, David G. Hirst, & Jeremy Brown. (1986). The effects of purine nucleoside analogs on the response of the rif-1 tumor to melphalan in vivo. International Journal of Radiation Oncology*Biology*Physics. 12(5). 801–806. 3 indexed citations
19.
Goldfeder, Anna, et al.. (1979). Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.. PubMed. 39(8). 2966–70. 9 indexed citations
20.
Brown, Dennis & Ronald D. Robson. (1964). Effect of Anti-inflammatory Agents on Capillary Permeability and Œdema Formation. Nature. 202(4934). 812–813. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026